[go: up one dir, main page]

DE69411604D1 - Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung - Google Patents

Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung

Info

Publication number
DE69411604D1
DE69411604D1 DE69411604T DE69411604T DE69411604D1 DE 69411604 D1 DE69411604 D1 DE 69411604D1 DE 69411604 T DE69411604 T DE 69411604T DE 69411604 T DE69411604 T DE 69411604T DE 69411604 D1 DE69411604 D1 DE 69411604D1
Authority
DE
Germany
Prior art keywords
preparation
drug composition
drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69411604T
Other languages
English (en)
Other versions
DE69411604T2 (de
Inventor
Yoshio Kanaya
Hiroshi Yuasa
Daisaku Oguni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Application granted granted Critical
Publication of DE69411604D1 publication Critical patent/DE69411604D1/de
Publication of DE69411604T2 publication Critical patent/DE69411604T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69411604T 1993-01-25 1994-01-25 Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung Expired - Fee Related DE69411604T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02854793A JP3390477B2 (ja) 1993-01-25 1993-01-25 薬剤組成物及びその製造法

Publications (2)

Publication Number Publication Date
DE69411604D1 true DE69411604D1 (de) 1998-08-20
DE69411604T2 DE69411604T2 (de) 1999-04-15

Family

ID=12251690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69411604T Expired - Fee Related DE69411604T2 (de) 1993-01-25 1994-01-25 Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung

Country Status (5)

Country Link
US (1) US5814621A (de)
EP (1) EP0609042B1 (de)
JP (1) JP3390477B2 (de)
CA (1) CA2114243A1 (de)
DE (1) DE69411604T2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031195A1 (en) * 1995-04-04 1996-10-10 Otsuka Pharmaceutical Co., Ltd. Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US8003705B2 (en) * 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US20090324721A1 (en) 1996-09-23 2009-12-31 Jack Kennedy Hydrogels Suitable For Use In Polyp Removal
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
EP1137373A4 (de) * 1998-12-04 2004-05-19 Chandrashekhar P Pathak Biokompatible, vernetzte polymere
JP4334869B2 (ja) * 2000-12-01 2009-09-30 協和発酵キリン株式会社 溶解性または経口吸収性の改善された組成物
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
EP1249247B1 (de) * 2001-03-30 2007-02-28 Chisso Corporation Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
PL373190A1 (en) * 2002-04-19 2005-08-22 Astion Development A/S Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
JP5148801B2 (ja) * 2002-09-09 2013-02-20 エスエス製薬株式会社 催眠用固形製剤
EP1796693A2 (de) * 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantierbare gewebezusammensetzungen und verfahren
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
AU2010350075B2 (en) 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
FR2958849A1 (fr) * 2010-04-14 2011-10-21 Boiron Medicament homeopathique a activite anti-cancereuse
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
WO2013086015A1 (en) 2011-12-05 2013-06-13 Incept, Llc Medical organogel processes and compositions
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887703A (en) * 1967-03-24 1975-06-03 Oreal Mucopolysaccharides, their preparation and use in cosmetic and pharmaceutical compositions
JPS5132718A (en) 1974-09-13 1976-03-19 Yoshinobu Nakai Nanyoseiyakuhin no yoshutsusokudochosetsuho
JPS5132719A (en) 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
JPS597117A (ja) 1982-07-02 1984-01-14 Teijin Ltd キトサン類を用いた製剤
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
JPS6163614A (ja) 1984-09-04 1986-04-01 Yamanouchi Pharmaceut Co Ltd 難溶性薬物の溶解速度向上方法
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
JPH0725689B2 (ja) 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
JPH0747548B2 (ja) 1986-10-16 1995-05-24 旭化成工業株式会社 薬物複合体
US4937270A (en) * 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
JPH02225422A (ja) 1989-02-28 1990-09-07 Kimitsu Kagaku Kogyo Kk 薬剤組成物
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2130295A1 (en) * 1993-08-26 1995-02-27 Richard A. Berg Ionically crosslinked glycosaminoglycan gels for soft tissue augmentation and drug delivery

Also Published As

Publication number Publication date
CA2114243A1 (en) 1994-07-26
DE69411604T2 (de) 1999-04-15
JPH06219938A (ja) 1994-08-09
EP0609042A1 (de) 1994-08-03
JP3390477B2 (ja) 2003-03-24
EP0609042B1 (de) 1998-07-15
US5814621A (en) 1998-09-29

Similar Documents

Publication Publication Date Title
DE69411604D1 (de) Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung
DE69518031D1 (de) Feste fettlösliche Zusammensetzung und Verfahren zu ihrer Herstellung
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
DE69229826D1 (de) Tensidzusammensetzung und Verfahren zu ihrer Herstellung
DE69214306D1 (de) Organopentasiloxan und Verfahren zu seiner Herstellung
ATA902992A (de) Antigeschwulstmittel und verfahren zu ihrer herstellung
DE69314950D1 (de) Okulaerdarreichungsform und verfahren zu ihrer herstellung
DE69310402D1 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung
DE59408355D1 (de) Cycloolefincopolymere und Verfahren zu ihrer Herstellung
DE68928527D1 (de) Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung
DE69216772D1 (de) Medizinische Behälter und Verfahren zu ihrer Herstellung
DE69302810D1 (de) Verbundwerkstoffe und verfahren zu ihrer herstellung
DE69522372D1 (de) Polyasparaginsäurederivate und Verfahren zu ihrer Herstellung
DE4498692T1 (de) Pharmazeutische Kompositionen zum Vorbeugen und Heilen von Krebserkrankungen und Verfahren zu ihrer Herstellung
DE69301771D1 (de) T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung
DE69224861D1 (de) Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
DE69608490D1 (de) Maltitol Zusammensetzung und Verfahren zu ihrer Herstellung
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69510774D1 (de) Katschukzusammensetzung und verfahren zu ihrer herstellung
DE69305256D1 (de) Wässrige Dispersionszusammensetzung und Verfahren zu ihrer Herstellung
DE69114420D1 (de) Organozyklosiloxane und Verfahren zu ihrer Herstellung.
DE69106627D1 (de) Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung.
DE69520118D1 (de) Cyclopropanderivate und Verfahren zu ihrer Herstellung
DE69225625D1 (de) Carbaminsäurederivate und Verfahren zu ihrer Herstellung
DE69502772D1 (de) Baccatinderivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOETERS & LIECK, 81541 MUENCHEN

8339 Ceased/non-payment of the annual fee